abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphLinkedInlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb

Esta página no está disponible en Español y está siendo mostrada en English

Artículo

24 Jul 2001

Autor:
Pharmaceutical Research and Manufacturers of America [PhRMA]

DTC Advertising Informs Patients About Untreated Diseases, New Treatments, PhRMA Tells Senate Subcommittee [USA]

Direct-to-consumer (DTC) advertising of prescription medicines informs consumers about new medical treatments and improves public health, Gregory J. Glover, M.D., J.D., told the Subcommittee on Consumer Affairs, Foreign Commerce, and Tourism of the Senate Committee on Commerce, Science and Transportation at a hearing today. Glover, a licensed physician and practicing attorney represented the Pharmaceutical Research and Manufacturers of America (PhRMA).